Patients at high risk of recurrent venous thromboembolism after initial treatment with full-dose anticoagulants for 6–24 months were randomly assigned to either reduced-dose or full-dose apixaban or ...

Venous thromboembolism (VTE) risk varies across hormonal contraceptives, according to a research letter published online.

The risk for cancer increases after cerebral venous thrombosis, especially in men older than 50 years; a new study calls for ...

Venous Thromboembolism Treatment Market The venous Thromboembolism Treatment Market growth is driven by rising VTE prevalence, anticoagulan ...

Cerebral venous thrombosis is a rare but potentially life-threatening condition that is particularly prevalent in young women (ie, mean age 44 years) and accounts for 0·5–3% of all strokes. The ...

Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...

The researchers found that per 10,000 person-years, the standardized VTE rates were 2.0, 10.0, 8.0, 8.1, 3.6, 2.1, 3.4, and 11.9 for nonuse, combined pills, vaginal ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

THURSDAY, Feb. 13, 2025 (HealthDay News) -- Venous thromboembolism (VTE) risk varies across hormonal contraceptives, according to a research letter published online Feb. 10 in the Journal of the ...

Wembanyama's clot was discovered, according to The Athletic's Sam Amick, because Wembanyama had experienced low energy ...

Background Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep venous thrombosis (DVT), can be life threatening. An increased frequency of VTE has been found in inflammatory ...